These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8856283)

  • 41. Predialysis management of chronic renal failure.
    Bidwell GC
    Ariz Med; 1982 Apr; 39(4):253-5. PubMed ID: 7049128
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials.
    Kikić Z; Lorenz M; Sunder-Plassmann G; Schillinger M; Regele H; Györi G; Mühlbacher F; Winkelmayer WC; Böhmig GA
    Transplantation; 2009 Dec; 88(12):1377-85. PubMed ID: 20029334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal lipoprotein (a) and lipid profiles in renal allograft recipients: effects of treatment with pravastatin.
    Lye WC; Hughes K; Leong SO; Tan CC; Lee EJ
    Transplant Proc; 1995 Feb; 27(1):977-8. PubMed ID: 7879252
    [No Abstract]   [Full Text] [Related]  

  • 44. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
    J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Apolipoprotein C-I, C-II, C-III].
    Fukushima N; Yamamoto K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():110-3. PubMed ID: 15658276
    [No Abstract]   [Full Text] [Related]  

  • 46. Lipoprotein abnormalities in chronic haemodialysis patients.
    Parsy D; Dracon M; Cachera C; Parra HJ; Vanhoutte G; Tacquet A; Fruchart JC
    Nephrol Dial Transplant; 1988; 3(1):51-6. PubMed ID: 3132640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients.
    Heimann P; Josephson MA; Fellner SK; Thistlethwaite JR; Stuart FP; Dasgupta A
    Am J Nephrol; 1991; 11(6):470-4. PubMed ID: 1840233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Glomerular filtration--the best measure of renal function].
    Aurell M; Frennby B; Sterner G; Sixt R; Christensson A
    Lakartidningen; 2002 Sep; 99(38):3686-90, 3692-4. PubMed ID: 12389250
    [No Abstract]   [Full Text] [Related]  

  • 49. Association between the SstI polymorphism of the apolipoprotein C-III gene, glucose intolerance and cardiovascular risk in renal transplant recipients.
    Rodrigo E; González-Lamuño D; Ruiz JC; Fresnedo GF; Isla D; Cotorruelo JG; Zubimendi JA; de Francisco AL; Garcia-Fuentes M; Arias M
    Transplant Proc; 2002 Feb; 34(1):379. PubMed ID: 11959336
    [No Abstract]   [Full Text] [Related]  

  • 50. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased lipoprotein (a) levels in subjects with chronic renal failure on hemodialysis.
    Barbagallo CM; Averna MR; Scafidi V; Galione A; Notarbartolo A
    Nephron; 1992; 62(4):471-2. PubMed ID: 1300447
    [No Abstract]   [Full Text] [Related]  

  • 52. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Terminal kidney failure. The transplantation is the first choice of renal replacement therapy].
    MMW Fortschr Med; 2009 Nov; 151(48):16. PubMed ID: 20085055
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of renal function in transplantation.
    Poggio ED; Batty DS; Flechner SM
    Transplantation; 2007 Jul; 84(2):131-6. PubMed ID: 17667802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of haemodialysis and peritoneal dialysis on serum lipoprotein(a) and C-reactive protein levels.
    Borazan A; Ustün H; Yilmaz A
    J Int Med Res; 2003; 31(5):378-83. PubMed ID: 14587304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Relation of serum apolipoprotein B100 levels to lipids and apolipoproteins A I, A II, C II, C III and E levels in the middle and old age normal males in Chengdu area].
    Wu Z; Liu B; Liu Y; Fang D; Zhang R
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar; 28(1):14-7. PubMed ID: 10684054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitation of plasminogen epitopes of serum lipoprotein(a) by sandwich enzyme linked immunosorbent assay.
    Wang JJ; Zhaung YY; Yao XD
    Clin Chim Acta; 1997 Sep; 265(1):121-30. PubMed ID: 9352135
    [No Abstract]   [Full Text] [Related]  

  • 58. Lipoprotein(a) concentration in patients with renal diseases.
    Elisaf M; Siamopoulos KC
    Am J Kidney Dis; 1996 Aug; 28(2):307. PubMed ID: 8768931
    [No Abstract]   [Full Text] [Related]  

  • 59. Pulmonary function in chronic renal failure: effect of dialysis and transplantation.
    Egan J; Kalra S; Woodcock A
    Thorax; 1991 Nov; 46(11):861. PubMed ID: 1663277
    [No Abstract]   [Full Text] [Related]  

  • 60. Low-molecular-weight heparin and lipoprotein(a) in patients with chronic renal failure.
    Sagripanti A; Cozza V; Barsotti G
    Nephron; 1997; 76(1):123-4. PubMed ID: 9171316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.